Saturday, January 09, 2021 5:47:31 AM
The abstract for both are identical and the claims for 8066982 appear to be a continuation of 7479538.
This brings me to the Cannaworx connection.
On their website CannaWorx lists patent 8309072 for their product ImmunaZin. Harry is also the inventor of this patent with the current assignee of The Zhabilov Trust.
The abstract for this patent (8309072) includes anti-cancer verbiage along with amino acid sequences followed by the same exact text from the previous two patents. The claims are also a continuation of the previous patents with the newly included anti-cancer text.
The section titled Cross-Reference To Related Applications claims that this patent (8309072) is essentially a continuation of the two patents listed for Virogentics (7479539 & 8066982).
Circling back to the Patent License Agreement from December 2nd, the final statement
From 8309072 (Cannaworx / Immunazin):
AU 678202 B
WO WO/2007/041285
From 7479538:
AU 678202 B (listed on both in the Foreign Patent Documents section)
JP 07316191
The AU is an Australia patent, the JP is Japan and the WO is World Intellectual Property Organization (WIPO)
Interestingly the WIPO patent applicant listed on their website is Viral Genetics, Inc.
I was originally reading through these patents to provide my girlfriends care team with the information they would need to give us a green light for her to take Immunazin as an immune system booster while she is undergoing chemo and radiation. But I somehow landed back on these posts from last year when I was reading through the FDA documents and then the Patents.
Please let me know your thoughts regarding the connections. I may in fact just be tired and reading too much into things. But in any case, reading the patents and FDA docs was a fun journey.
Here are the links for the Patent PDFs:
US8309072B2 (Immunazin)
US8066982B2
US7479538B2
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
- MWRK Positions For High Growth In $3.5 Trillion Metaverse Market Popularized By META • InvestorsHub NewsWire • 05/03/2023 04:24:58 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM